Skip to main content
logo
MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.245
+0.035 (2.89%)
Jan 21, 2026, 3:07 PM EST - Market open

MaxCyte Revenue

MaxCyte had revenue of $6.83M in the quarter ending September 30, 2025, a decrease of -16.35%. This brings the company's revenue in the last twelve months to $34.42M, down -24.52% year-over-year. In the year 2024, MaxCyte had annual revenue of $38.63M, down -6.44%.

Revenue (ttm)
$34.42M
Revenue Growth
-24.52%
P/S Ratio
3.73
Revenue / Employee
$301,921
Employees
114
Market Cap
132.81M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202438.63M-2.66M-6.44%
Dec 31, 202341.29M-2.97M-6.72%
Dec 31, 202244.26M10.37M30.59%
Dec 31, 202133.89M7.73M29.52%
Dec 31, 202026.17M4.55M21.04%
Dec 31, 201921.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inogen347.03M
Treace Medical Concepts218.88M
Neuronetics129.87M
AVITA Medical72.40M
LENSAR59.14M
CVRx, Inc.55.97M
Apyx Medical47.90M
Hyperfine10.59M
Revenue Rankings

MXCT News

More News